Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-TAA monoclonal antibody-chelator conjugate BAY3547922

An immunoconjugate comprised of a monoclonal antibody directed against an as of yet undisclosed tumor-associated antigen (TAA) conjugated to an as of yet undisclosed chelator. When bound to the radioisotope zirconium Zr 89 (Zr89), the monoclonal antibody moiety of anti-TAA monoclonal antibody-chelator conjugate BAY3547922 specifically targets and binds to the TAA expressed on tumor cells, which may allow the tracing of TAA-expressing tumor cells upon positron emission tomography/computed tomography (PET/CT).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:monoclonal antibody-chelator conjugate BAY3547922
Code name:BAY 3547922
BAY-3547922
BAY3547922
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search